Antilymphocyte antibodies were found in 51 of 83 serum specimens from Thai children with dengue hemorrhagic fever (DHF). The lymphocytotoxic activity was complement dependent, and cytotoxicity was detected in the 19S immunoglobulin M-associated serum fractions at a temperature optimum of 15°C. Sera with lymphocytotoxic activity were cytotoxic to autologous as well as allogeneic lymphocytes from patients and healthy adult donors and were directed primarily against B cells, with some T cell cross-reactivity. This study suggests that infection with DHF induces predominately cold-reactive antilymphocyte antibodies in DHF patients that could potentially interact with peripheral blood cells of patients and modulate the humoral immune responses of patients during infection.
The presence of antilymphocyte antibodies (ALA) in the sera of patients with autoimmune (14) , parasitic (16) , or viral diseases (5, 12 ) is well documented. These lymphocytotoxic antibodies differ from conventional cytotoxins in that they are autocytotoxic and are complement and temperature (15°C) dependent (10, 11) , and their presence is independent of allogeneic immunization. Although the role of ALA in the immunopathogenesis or manifestation of the diseases in which they are found is unclear, they may interact with cells or other serum factors to modulate the immune responses of the patients.
Recently, Wells et al. (17) have reported that major alterations occur within several component cell subpopulations in the immune system of Thai children with dengue hemorrhagic fever (DHF). These alterations include a significant increase in atypical lymphocytes and non-T, non-B, non-Fc receptor-bearing Null cells and a significant decrease in T cells in the peripheral blood of DHF patients. In addition, Boonpucknavig et al. (2) have used indirect immunofluorescence to show that ALA are present in the sera of patients with DHF; however, they did not determine the incidence, nature, or characteristics of these ALA. We now report that 61.4% of sera from Thai (20) . Nonheparinized blood was clotted at room temperature to obtain serum, and serological confirmation of DHF was proven by using the hemagglutination inhibition test. Control sera were obtained from healthy Thai school children as well as healthy Thai adults. The control sera were also examined by hemagglutination inhibition (see below and Isolation of peripheral blood lymphocytes and lymphocyte subpopulations. Peripheral blood lymphocytes were prepared from heparinized venous blood that was centrifuged through Ficoll-Hypaque (3) , washed three times with Hanks balanced salt solution, and suspended in RPMI 1640 supplemented with 2 mM glutamine, 50 U of penicillin, 50 ,ug of streptomycin per ml, 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer (HEPES), and 10% heatinactivated fetal calf serum. In certain experiments, the cells were further separated into subpopulations as previously described (8) . Briefly, the isolated cells were passed over a Sephadex G-10 column to remove adherent cells. The nonadherent cells were then sepa-rated into T, B, and Null cells in a two-stage process. First, the cells were poured over a Sephadex G-200 anti-human F(ab')2 immunoabsorbent column. Then, the nonadherent T plus Null cells were further fractionated by using overnight incubation with sheep erythrocytes, followed by Ficoll-Hypaque density centrifugation. The adherent cells (B cells) were eluted from the column with medium containing 1% human immunoglobulin, incubated overnight with sheep erythrocytes, and centrifuged over Ficoll-Hypaque to remove any contaminating T cells (8) . Surface characteristic determinations of the enriched cell populations were performed as previously described (8) . All populations were highly enriched, and viability of the final preparation was greater than 95%.
Lymphocytotoxic antibody assays. The methodology for the ALA assays has been described previously (16) . Briefly, at either 4, 15, or 37°C, 0.1 ml of each serum or a fraction of the sera obtained by sucrose gradient fractionation was added in duplicate to appropriate wells for 30 min, followed by the addition of 0.1 ml of fresh rabbit serum (as a source of complement). Then, after an additional 3 h of incubation, the percentage of dead cells was determined by eosin dye inclusion. Sera with high lymphocytotoxicity from malarious patients or patients with systemic lupus erythematosus served as positive controls. Some sera with lymphocytotoxic activity were subsequently tested for the presence of ALA against a panel of lymphocytes from 10 normal adults of various human lymphocyte antigen phenotypes.
The microcytotoxicity assays were modified when sera were tested for lymphocytotoxicity against enriched T cell, B cell, Null cell, or macrophage targets. Sera were distributed on Terasaki microtiter trays which had been covered with mineral oil; 1 p.1 of serum was added to each well, and the trays were stored at -70°C until needed. The assays were performed by putting 1 pl of target cell suspension (2 x 106 lymphocytes per ml) into each well containing test sera. The target cell-serum mixture was incubated for 1 h; 5 pJ of rabbit comnplement (Pel Freeze) was added to each well, and the mixture was further incubated for 3 h.
Aqueous eosin (3 ,u of a 5% solution) was then added to each well; 2 min later, 10 ,ul of Formalin was added to the wells, and the tray was covered with a microscope slide (50 by 75 mm). Target cell death was deterinied by using a phase-contrast microscope.
Sucrose densiy fractioation of serum. Sucrose density centrifugation of serum was performed by layering the serum over a 10 to 40% linear sucrose gradient from which 12 equal fractions were subsequently collected after centrifugation (7 -cimens from In 6 of 13 cases, the sera of patients with DHF otoxic activi-were cytotoxic (>7.6% mean ± SD of adult illing) against control sera cytotoxicity) to the patients' own when the mi-lymphocytes. An equivalent level of lymphocyLt 15°C with a totoxic antibody activity was found when the ,A activity in serum specimens containing antibody were testof 4.5% nor-ed against allogeneic lymphocytes from other whereas only patients and healthy donors. Thus, sera from from healthy patients with DHF which contained antibodies D = 9.1 + 0.2 cytotoxic to allogeneic lymphocytes contained t control sera antibodies against the patients' own lymphoEight of the cytes as well. When patients' positive ALA sera which did not were serially diluted and tested against allogeneiositive when ic mononuclear target cells from healthy Thai s. Moreover, donors, ALA were absent or substantially de-[emonstrating creased to between a 1:4 and a 1:16 dilution. serologically
Thirteen sera from patients with acute DHF Mean lym-were tested against T cell-, B cell-, and Null cellpatients dif-enriched target subpopulations. In a small numlymphocyto-ber of experiments, patient sera with strong s sera (0.05 < ALA against unfractionated MNC were tested ra (P < 0.05). against monocyte-macrophage-enriched (>85% serum speci-esterase positive) target subpopulations. ALA iphocytotoxic were primarily directed against B cells (38%), el of lympho-and, in a number of instances (31%), against he 13 individ-both T cells and B cells. Only occasional sera ast 20% cyto-(8%) reacted with T cells alone. (19) .
Although the absence of cytotoxicity in whole serum at 37°C raises the possibility that lymphocytotoxic antibodies in DHF sera may not cause in vivo complement-mediated lymphocytolysis (18) , it should be noted that the temperature in the peripheral circulation of patients is lower and that the antibodies could attach and lead to cell surface modulation in the periphery. It is possible that optimal cytotoxicity at 15°C represents a compromise between lower and higher temperature for binding and complement fixation, respectively. In vivo and in vitro observations on lymphocytotoxins in other human diseases suggest that at 37°C, lymphocytes may be able to process lymphocytotoxic antibodies effectively. This has been proposed to result from pinocytosis (13) 
